Pascale Lejeune

SAR650984, A Novel Humanized CD38-Targeting Antibody, Demonstrates Potent Antitumor Activity in Models of Multiple Myeloma and Other CD38+ Hematologic Malignancies

Jutta Deckert, Marie-Cécile Wetzel, Laura M. Bartle et al. · Clinical Cancer Research · 2014 · 321 citations

Transcriptional addiction in cancer cells is mediated by YAP/TAZ through BRD4

Francesca Zanconato, Giusy Battilana, Mattia Forcato et al. · Nature Medicine · 2018 · 304 citations · Full text

Tumor Biology, Transcriptional Regulation, Signal Transduction +13

The novel dihydroorotate dehydrogenase (DHODH) inhibitor BAY 2402234 triggers differentiation and is effective in the treatment of myeloid malignancies

Sven Christian, Claudia Merz, Laura Evans et al. · Leukemia · 2019 · 232 citations · Full text

Mixed-phenotype Acute Leukemia, Genetics, Pathology +17

Preclinical Antitumor Activity of Cabazitaxel, a Semisynthetic Taxane Active in Taxane-Resistant Tumors

Patricia Vrignaud, Dorothée Sémiond, Pascale Lejeune et al. · Clinical Cancer Research · 2013 · 221 citations

The Novel ATR Inhibitor BAY 1895344 Is Efficacious as Monotherapy and Combined with DNA Damage–Inducing or Repair–Compromising Therapies in Preclinical Cancer Models

Antje M. Wengner, Gerhard Siemeister, Ulrich Lücking et al. · Molecular Cancer Therapeutics · 2019 · 200 citations